期刊文献+

转化生长因子β1与二甲基精氨酸二甲胺水解酶2在早期肺腺癌中的表达及其临床意义

Expressions of transforming growth factorβ1 and dimethylarginine dimethylaminohydrolase 2 in early-stage lung adenocarcinoma and their clinical significances
原文传递
导出
摘要 目的:探讨转化生长因子β 1(TGF-β 1)与二甲基精氨酸二甲胺水解酶2(DDAH2)在早期肺腺癌不同阶段病变中的表达情况及其意义,为肺腺癌精准病理诊断提供依据。 方法:选取山西白求恩医院2012年1月至2019年6月62例早期肺腺癌患者手术切除标本,大部分标本包含1种以上病理类型。按照病理类型分为3组:非典型腺瘤样增生(AAH)18例、原位腺癌(AIS)60例、微浸润腺癌(MIA)、以附壁生长方式为主的浸润性腺癌(LPA)中的浸润性癌(CA)成分55例,选取各样本癌旁正常肺组织作为对照。采用免疫组织化学法检测TGF-β 1、DDAH2蛋白在各病理类型病变组织和对照组织中的表达情况,分析二者的相关性。 结果:TGF-β 1、DDAH2蛋白均在正常肺组织上皮细胞中表达,阳性率分别为46.8%(29/62)、98.4%(61/62);在AAH、AIS及CA组织上皮细胞中,TGF-β 1、DDAH2蛋白阳性率均依次升高,其中TGF-β 1蛋白阳性率分别为16.7%(3/18)、31.7%(19/60)、70.9%(39/55),DDAH2蛋白阳性率分别为66.6%(12/18)、81.7%(49/60)、90.1%(49/55),各病理类型间二者阳性率差异均有统计学意义(均 P<0.01)。TGF-β 1、DDAH2蛋白在正常肺组织、AAH、AIS及CA组织间质成纤维细胞中阳性率均呈依次升高的趋势,其中TGF-β 1蛋白阳性率分别为11.3%(7/62)、61.1%(11/18)、72.3%(44/60)、83.6%(46/55),DDAH2蛋白阳性率分别为0(0/62)、22.2%(4/18)、65.0%(39/60)、98.2%(54/55),各病理类型间二者阳性率差异均有统计学意义(均 P<0.01)。肺腺癌病变组织中,上皮细胞TGF-β 1与间质成纤维细胞DDAH2蛋白表达呈正相关( r=0.221, P=0.011)。 结论:TGF-β 1、DDAH2蛋白在早期肺腺癌各病理类型病变组织中的表达趋势可能与病变程度相关,二者联合检测有望成为辅助诊断早期肺腺癌不同病理类型的生物学标志物。 Objective To investigate the expressions and significances of transforming growth factorβ1(TGF-β1)and dimethylarginine dimethylaminohydrolase 2(DDAH2)in different stages of early-stage lung adenocarcinoma,and to provide basis for accurate pathological diagnosis of lung adenocarcinoma.Methods Sixty-two surgical specimens from patients with early-stage lung adenocarcinoma in Shanxi Bethune Hospital from January 2012 to June 2019 were selected.Most of the specimens contained more than one pathological type.According to the pathological types,they were divided into three groups:18 cases of atypical adenomatous hyperplasia(AAH),60 cases of adenocarcinoma in situ(AIS),and 55 cases of invasive carcinoma(CA)component in minimally invasive adenocarcinoma(MIA)and lepidic predominant adenocarcinoma(LPA),and the wall attached growth patterns were selected as control group.Immunohistochemistry was used to detect the expressions of TGF-β1 and DDAH2 proteins in different pathological types of lesions and control tissues,and the correlation among them was analyzed.Results TGF-β1 and DDAH2 proteins were expressed in normal lung tissue epithelial cells,and the positive rates were high[46.8%(29/62)and 98.4%(61/62)].The positive rates of TGF-β1 and DDAH2 proteins in epithelial cells of AAH,AIS and CA increased gradually,the positive rate of TGF-β1 protein was 16.7%(3/18),31.7%(19/60)and 70.9%(39/55),the positive rate of DDAH2 protein was 66.6%(12/18),81.7%(49/60)and 90.1%(49/55),and the differences of positive rates among different pathological types were statistically significant(all P<0.01).The positive rates of TGF-β1 and DDAH2 protein in interstitial fibroblasts of normal lung tissue,AAH,AIS and CA increased gradually,the positive rate of TGF-β1 protein was 11.3%(7/62),61.1%(11/18),72.3%(44/60),and 83.6%(46/55),the positive rate of DDAH2 protein was 0(0/62),22.2%(4/18),65.0%(39/60),and 98.2%(54/55),and the differences of positive rates among different pathological types were statistically significant(all P<0.01).In lung
作者 侯丽娟 李丽 王琳 张振华 胡丽娜 司彩风 刘小红 Hou Lijuan;Li Li;Wang Lin;Zhang Zhenhua;Hu Lina;Si Caifeng;Liu Xiaohong(Graduate School,Shanxi Medical University,Taiyuan 030001,China;Department of Pathology,Shanxi Bethune Hospital,Taiyuan 030032,China)
出处 《肿瘤研究与临床》 CAS 2020年第11期760-765,共6页 Cancer Research and Clinic
基金 山西省卫生健康委员会科研课题(2018012)。
关键词 肺肿瘤 腺癌 成纤维细胞 转化生长因子Β1 二甲基精氨酸二甲胺水解酶2 Lung neoplasms Adenocarcinoma Fibroblasts Transforming growth factorβ1 Dimethylarginine dimethylaminohydrolase 2
  • 相关文献

参考文献6

二级参考文献34

  • 1Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300. 被引量:1
  • 2International Early Lung Cancer Action Program Investigators,Henschke CI,Yankelevitz DF,et al.Survival of patients with stage I lung cancer detected on CT screening[J].N Engl J Med,2006,355(17):1763-1771. 被引量:1
  • 3National Lung Screening Trial Research Team,Aberle DR,Adams AM,et al.Reduced lung-cancer mortality with lowdose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409. 被引量:1
  • 4Eberhardt R,Anantham D,Herth F,et al.Electromagnetic navigation diagnostic bronchoscopy in peripheral lung lesions[J].Chest,2007,13l(6):1800-1805. 被引量:1
  • 5Eberhardt R,Anantham D,Ernst A,et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial[J].Am J Respir Crit Care Med,2007,176(1):36-41. 被引量:1
  • 6Silvestri GA,Gould MK,Margolis ML,et al.Noninvasive staging of non-small cell lung cancer:ACCP evidenced-based clinical practice guidelines(2nd edition)[J].Chest,2007,132(3Suppl):178S-201S. 被引量:1
  • 7Gould MK,Kuschner WG,Rydzak CE,et al.Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer:a meta-analysis[J].Ann Intern Med,2003,139(11):879-892. 被引量:1
  • 8Yasufuku K,Nakajima T,Fujiwara T,et al.Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer[J].Gen Thorac Cardiovsac Surg,2008,56(6):268-276. 被引量:1
  • 9Lee HS,Lee GK,Lee HS,et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer:how many aspirations per target lymph node station[J].Chest,2008,134(2):368-374. 被引量:1
  • 10Hwangbo B,Kim SK,Lee HS,et al.Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer[J].Chest,2009,135(5):1280-1287. 被引量:1

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部